Facebook Linkedin RSS Twitter Youtube
Home 2020

Anthrax vaccine

Intranasal Anthrax Vaccine Candidate “Off to the Races”
Drug Discovery

Intranasal Anthrax Vaccine Candidate “Off to the Races”

Emergent Confirms $100M BARDA Contract for Anthrax Vaccine Stockpiling
Industry News

Emergent Confirms $100M BARDA Contract for Anthrax Vaccine Stockpiling

Altimmune Awarded Up to $120.2M for Anthrax Vaccine Candidate
Drug Discovery

Altimmune Awarded Up to $120.2M for Anthrax Vaccine Candidate

PharmAthene Partners with Immunovaccine to Develop Anthrax Vaccine
News

PharmAthene Partners with Immunovaccine to Develop Anthrax Vaccine

FDA Places Second Clinical Hold on PharmAthene’s Anthrax Vaccine
News

FDA Places Second Clinical Hold on PharmAthene’s Anthrax Vaccine

Needle-Free Anthrax Vaccine Wins NIAID Contract
Bioprocessing

Needle-Free Anthrax Vaccine Wins NIAID Contract

BARDA Pushes on With Anthrax Vaccine Development
Drug Discovery

BARDA Pushes on With Anthrax Vaccine Development

Funding for Anthrax Antitoxin Hits $149M
Drug Discovery

Funding for Anthrax Antitoxin Hits $149M

Soligenix Wins $600K SBIR Grant to Develop Radiation Sickness Drug
Industry News

Soligenix Wins $600K SBIR Grant to Develop Radiation Sickness Drug

Emergent BioSolutions Secures $8.43M to Test Anthrax Vaccine in Postexposure Setting
Infectious Diseases

Emergent BioSolutions Secures $8.43M to Test Anthrax Vaccine in Postexposure Setting

123Page 1 of 3
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.